March 30, 2009 - GE Healthcare showed new technology for cardiovascular CTA to improve image quality and workflow, while reducing radiation dose during the 58th Annual American College of Cardiology (ACC) meeting.
March 30, 2009 - Beaumont Hospitals, based in Royal Oak, MI, will be expanding its current IMPAX radiology PACS (Picture Archiving and Communication System) to include IMPAX Cardiovascular for imaging and reporting in its cardiology department.
March 30, 2009 - The FDA and Watson Pharmaceuticals notified healthcare professionals and patients of a recall of cardiac arrhythmias drug Propafenone HCL 225 mg tablets because some tablets may contain slightly higher levels of the active ingredient than specified.
March 30, 2009 - New analysis from the JUPITER study presented at the ACC in Orlando, FL shows that CRESTOR (rosuvastatin calcium) 20mg significantly cut the risk of venous thromboembolism (VTE) by 43 percent (p =0.007) compared to placebo among men and women with low to normal cholesterol levels and elevated high-sensitivity C-reactive protein (hsCRP).
March 30, 2009 - GE Healthcare and Archimedes Inc., an independent Healthcare Modeling organization, announced at ACC that they will collaborate to launch a new virtual study to identify an enhanced diagnostic protocol for predicting coronary heart disease (CHD).
March 30, 2009 - Agfa HealthCare’s latest version of its IMPAX HeartStation, a comprehensive management system for electrocardiograms (ECGs) is now available.
IMPAX HeartStation features expanded compatibility with ECG carts from multiple market leading vendors, including GE, Philips, Mortara and Schiller.
March 30, 2009 - Impulse Dynamics announced findings from the FIX-HF-5 study of its OPTIMIZER System at the 58th Annual Scientific Session of the American College of Cardiology in Orlando, FL, demonstrating positive longer term effects of the system’s cardiac contractility modulation (CCM) signals.
March 30, 2009 - An AHRQ-funded study finds a lower risk of death and heart attack in heart disease patients 65 and older who were treated with drug-coated stents to prevent blockages as compared to patients treated with bare metal stands.
